{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T12:53:36Z","timestamp":1780836816119,"version":"3.54.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["2014"],"award-info":[{"award-number":["2014"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["2015-2666"],"award-info":[{"award-number":["2015-2666"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1007\/s00018-022-04467-z","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T08:44:53Z","timestamp":1658997893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sleep-controlling neurons are sensitive and vulnerable to multiple forms of \u03b1-synuclein: implications for the early appearance of sleeping disorders in \u03b1-synucleinopathies"],"prefix":"10.1007","volume":"79","author":[{"given":"Altair B.","family":"Dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line K.","family":"Skaanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siganya","family":"Thaneshwaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyd","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar R.","family":"Romero-Leguizam\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skamris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten P.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette E.","family":"Langkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0183-3816","authenticated-orcid":false,"given":"Kristi A.","family":"Kohlmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"4467_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","volume":"16","author":"CH Hawkes","year":"2010","unstructured":"Hawkes CH, Del Tredici K, Braak H (2010) A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord 16:79\u201384. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.08.007","journal-title":"Parkinsonism Relat Disord"},{"key":"4467_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-150685","volume":"5","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Seppi K, Poewe W (2015) The concept of prodromal Parkinson\u2019s disease. J Parkinsons Dis 5:681\u2013697. https:\/\/doi.org\/10.3233\/JPD-150685","journal-title":"J Parkinsons Dis"},{"key":"4467_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH et al (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30:1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"key":"4467_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1474-4422(16)00057-0","volume":"15","author":"A Iranzo","year":"2016","unstructured":"Iranzo A, Santamaria J, Tolosa E (2016) Idiopathic rapid eye movement sleep behaviour disorder: diagnosis, management, and the need for neuroprotective interventions. Lancet Neurol 15:405\u2013419. https:\/\/doi.org\/10.1016\/S1474-4422(16)00057-0","journal-title":"Lancet Neurol"},{"key":"4467_CR5","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1212\/WNL.0000000000001364","volume":"84","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Gagnon J-F, Bertrand J-A et al (2015) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84:1104\u20131113. https:\/\/doi.org\/10.1212\/WNL.0000000000001364","journal-title":"Neurology"},{"key":"4467_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s11064-014-1488-7","volume":"40","author":"AB dos Santos","year":"2015","unstructured":"dos Santos AB, Kohlmeier KA, Barreto GE (2015) Are sleep disturbances preclinical markers of Parkinson\u2019s disease? Neurochem Res 40:421\u2013427. https:\/\/doi.org\/10.1007\/s11064-014-1488-7","journal-title":"Neurochem Res"},{"key":"4467_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fnagi.2014.00273","volume":"6","author":"AB dos Santos","year":"2014","unstructured":"dos Santos AB, Barreto GE, Kohlmeier KA (2014) Treatment of sleeping disorders should be considered in clinical management of Parkinson\u2019s disease. Front Aging Neurosci 6:273. https:\/\/doi.org\/10.3389\/fnagi.2014.00273","journal-title":"Front Aging Neurosci"},{"key":"4467_CR8","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Prim 3:17013. https:\/\/doi.org\/10.1038\/nrdp.2017.13","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"4467_CR9","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ana.24385","volume":"77","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Iranzo A, Hogl B et al (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77(5):830\u2013839. https:\/\/doi.org\/10.1002\/ana.24385","journal-title":"Ann Neurol"},{"key":"4467_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma RB, Iranzo A, Hu M et al (2019) Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142:744\u2013759. https:\/\/doi.org\/10.1093\/brain\/awz030","journal-title":"Brain"},{"key":"4467_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5665\/sleep.5332","volume":"39","author":"A Fern\u00e1ndez-Arcos","year":"2016","unstructured":"Fern\u00e1ndez-Arcos A, Iranzo A, Serradell M et al (2016) The clinical phenotype of idiopathic rapid eye movement sleep behavior disorder at presentation: a study in 203 consecutive patients. Sleep 39:121\u2013132. https:\/\/doi.org\/10.5665\/sleep.5332","journal-title":"Sleep"},{"issue":"2","key":"4467_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089741","volume":"9","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Fern\u00e1ndez-Arcos A, Tolosa E et al (2014) Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS ONE 9(2):e89741. https:\/\/doi.org\/10.1371\/journal.pone.0089741","journal-title":"PLoS ONE"},{"issue":"15","key":"4467_CR13","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1212\/01.wnl.0000340980.19702.6e","volume":"72","author":"RB Postuma","year":"2009","unstructured":"Postuma RB, Gagnon JF, Vendette M et al (2009) Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 72(15):1296\u20131300. https:\/\/doi.org\/10.1212\/01.wnl.0000340980.19702.6e","journal-title":"Neurology"},{"key":"4467_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsx071","author":"TR Barber","year":"2017","unstructured":"Barber TR, Lawton M, Rolinski M et al (2017) Prodromal Parkinsonism and neurodegenerative risk stratification in REM sleep behavior disorder. Sleep. https:\/\/doi.org\/10.1093\/sleep\/zsx071","journal-title":"Sleep"},{"key":"4467_CR15","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1212\/WNL.46.2.388","volume":"46","author":"CH Schenck","year":"1996","unstructured":"Schenck CH, Bundlie SR, Mahowald MW (1996) Delayed emergence of a parkinsonian disorder in 38% of 29 older, men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 46:388\u2013393. https:\/\/doi.org\/10.1212\/WNL.46.2.388","journal-title":"Neurology"},{"key":"4467_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sleep.2012.10.009","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14:744\u2013748. https:\/\/doi.org\/10.1016\/j.sleep.2012.10.009","journal-title":"Sleep Med"},{"key":"4467_CR17","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","volume":"65","author":"RD Abbott","year":"2005","unstructured":"Abbott RD, Ross GW, White LR et al (2005) Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65:1442\u20131446. https:\/\/doi.org\/10.1212\/01.wnl.0000183056.89590.0d","journal-title":"Neurology"},{"key":"4467_CR18","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/aje\/kwq478","volume":"173","author":"J Gao","year":"2011","unstructured":"Gao J, Huang X, Park Y et al (2011) Daytime napping, nighttime sleeping, and Parkinson disease. Am J Epidemiol 173:1032\u20131038. https:\/\/doi.org\/10.1093\/aje\/kwq478","journal-title":"Am J Epidemiol"},{"key":"4467_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neuron.2017.02.027","volume":"94","author":"J Mena-Segovia","year":"2017","unstructured":"Mena-Segovia J, Bolam JP (2017) Rethinking the pedunculopontine nucleus: from cellular organization to function. Neuron 94:7\u201318. https:\/\/doi.org\/10.1016\/j.neuron.2017.02.027","journal-title":"Neuron"},{"key":"4467_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00702-016-1530-9","volume":"123","author":"J Mena-Segovia","year":"2016","unstructured":"Mena-Segovia J (2016) Structural and functional considerations of the cholinergic brainstem. J Neural Transm 123:731\u2013736. https:\/\/doi.org\/10.1007\/s00702-016-1530-9","journal-title":"J Neural Transm"},{"key":"4467_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cne.902160106","volume":"216","author":"DM Armstrong","year":"1983","unstructured":"Armstrong DM, Saper CB, Levey AI et al (1983) Distribution of cholinergic neurons in rat brain: Demonstrated by the immunocytochemical localization of choline acetyltransferase. J Comp Neurol 216:53\u201368. https:\/\/doi.org\/10.1002\/cne.902160106","journal-title":"J Comp Neurol"},{"issue":"2","key":"4467_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cne.903630203","volume":"363","author":"B Ford","year":"1995","unstructured":"Ford B, Holmes CJ, Mainville L, Jones BE (1995) GABAergic neurons in the rat pontomesencephalic tegmentum: codistribution with cholinergic and other tegmental neurons projecting to the posterior lateral hypothalamus. J Comp Neurol 363(2):177\u2013196. https:\/\/doi.org\/10.1002\/cne.903630203","journal-title":"J Comp Neurol"},{"key":"4467_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fnana.2011.00022","volume":"5","author":"C Martinez-Gonzalez","year":"2011","unstructured":"Martinez-Gonzalez C, Bolam JP, Mena-Segovia J (2011) Topographical organization of the pedunculopontine nucleus. Front Neuroanat 5:543. https:\/\/doi.org\/10.3389\/fnana.2011.00022","journal-title":"Front Neuroanat"},{"key":"4467_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1073\/pnas.1423136112","volume":"112","author":"CJ Van Dort","year":"2015","unstructured":"Van Dort CJ, Zachs DP, Kenny JD et al (2015) Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep. Proc Natl Acad Sci 112:584\u2013589. https:\/\/doi.org\/10.1073\/pnas.1423136112","journal-title":"Proc Natl Acad Sci"},{"key":"4467_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ana.410260106","volume":"26","author":"RM Zweig","year":"1989","unstructured":"Zweig RM, Jankel WR, Hedreen JC et al (1989) The pedunculopontine nucleus in Parkinson\u2019s disease. Ann Neurol 26:41\u201346. https:\/\/doi.org\/10.1002\/ana.410260106","journal-title":"Ann Neurol"},{"key":"4467_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U et al (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211. https:\/\/doi.org\/10.1016\/S0197-4580(02)00065-9","journal-title":"Neurobiol Aging"},{"key":"4467_CR27","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R et al (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with lewy bodies. Proc Natl Acad Sci U S A 95:6469\u20136473. https:\/\/doi.org\/10.1073\/pnas.95.11.6469","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4467_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fnana.2014.00159","volume":"8","author":"A Recasens","year":"2014","unstructured":"Recasens A, Dehay B (2014) Alpha-synuclein spreading in Parkinson\u2019s disease. Front Neuroanat 8:159. https:\/\/doi.org\/10.3389\/fnana.2014.00159","journal-title":"Front Neuroanat"},{"key":"4467_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11920-009-0004-2","volume":"11","author":"CL Deschenes","year":"2009","unstructured":"Deschenes CL, McCurry SM (2009) Current treatments for sleep disturbances in individuals with dementia. Curr Psychiatry Rep 11:20\u201326. https:\/\/doi.org\/10.1007\/s11920-009-0004-2","journal-title":"Curr Psychiatry Rep"},{"key":"4467_CR30","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3233\/jpd-212554","volume":"11","author":"AB Dos Santos","year":"2021","unstructured":"Dos Santos AB, Skaanning LK, Mikkelsen E et al (2021) \u03b1-Synuclein responses in the laterodorsal tegmentum, the pedunculopontine tegmentum, and the substantia nigra: implications for early appearance of sleep disorders in Parkinson\u2019s disease. j parkinsons dis 11:1773\u20131790. https:\/\/doi.org\/10.3233\/jpd-212554","journal-title":"j parkinsons dis"},{"key":"4467_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/JPD-150642","volume":"5","author":"j burr\u00e9","year":"2015","unstructured":"burr\u00e9 j (2015) the synaptic function of \u03b1-synuclein. J Parkinsons Dis 5:699\u2013713. https:\/\/doi.org\/10.3233\/JPD-150642","journal-title":"J Parkinsons Dis"},{"key":"4467_CR32","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nm.3457","volume":"20","author":"JL Guo","year":"2014","unstructured":"Guo JL, Lee VMY (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130\u2013138. https:\/\/doi.org\/10.1038\/nm.3457","journal-title":"Nat Med"},{"key":"4467_CR33","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1038\/ncomms3575","volume":"4","author":"L Bousset","year":"2013","unstructured":"Bousset L, Pieri L, Ruiz-Arlandis G et al (2013) Structural and functional characterization of two alpha-synuclein strains. Nat Commun 4:2575. https:\/\/doi.org\/10.1038\/ncomms3575","journal-title":"Nat Commun"},{"issue":"7556","key":"4467_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van Der Perren A et al (2015) \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522(7556):340\u2013344. https:\/\/doi.org\/10.1038\/nature14547","journal-title":"Nature"},{"key":"4467_CR35","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1242\/jcs.180737","volume":"129","author":"PR Angelova","year":"2016","unstructured":"Angelova PR, Ludtmann MHR, Horrocks MH et al (2016) Ca 2+ is a key factor in \u03b1-synuclein-induced neurotoxicity. J Cell Sci 129:1792\u20131801. https:\/\/doi.org\/10.1242\/jcs.180737","journal-title":"J Cell Sci"},{"key":"4467_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1089\/ars.2015.6343","volume":"24","author":"E Deas","year":"2016","unstructured":"Deas E, Cremades N, Angelova PR et al (2016) Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson\u2019s disease. Antioxid Redox Signal 24:376\u2013391. https:\/\/doi.org\/10.1089\/ars.2015.6343","journal-title":"Antioxid Redox Signal"},{"issue":"39","key":"4467_CR37","doi-asserted-by":"publisher","first-page":"E8284","DOI":"10.1073\/pnas.1710442114","volume":"114","author":"P Thakur","year":"2017","unstructured":"Thakur P, Breger LS, Lundblad M et al (2017) Modeling Parkinson\u2019s disease pathology by combination of fibril seeds and \u03b1-synuclein overexpression in the rat brain. Proc Natl Acad Sci 114(39):E8284\u2013E8293. https:\/\/doi.org\/10.1073\/pnas.1710442114","journal-title":"Proc Natl Acad Sci"},{"key":"4467_CR38","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1073\/PNAS.1013225108\/SUPPL_FILE\/PNAS.1013225108_SI.PDF","volume":"108","author":"L Giehm","year":"2011","unstructured":"Giehm L, Svergun DI, Otzen DE, Vestergaard B (2011) Low-resolution structure of a vesicle disrupting \u03b1-synuclein oligomer that accumulates during fibrillation. Proc Natl Acad Sci U S A 108:3246\u20133251. https:\/\/doi.org\/10.1073\/PNAS.1013225108\/SUPPL_FILE\/PNAS.1013225108_SI.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4467_CR39","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1021\/bm500937p","volume":"15","author":"A van Maarschalkerweerd","year":"2014","unstructured":"van Maarschalkerweerd A, Vetri V, Langkilde AE et al (2014) Protein\/lipid coaggregates are formed during \u03b1-synuclein-induced disruption of lipid bilayers. Biomacromol 15:3643\u20133654. https:\/\/doi.org\/10.1021\/bm500937p","journal-title":"Biomacromol"},{"key":"4467_CR40","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41598-018-38271-2","volume":"9","author":"T Skamris","year":"2019","unstructured":"Skamris T, Marasini C, Madsen KL et al (2019) Early stage alpha-synuclein amyloid fibrils are reservoirs of membrane-binding species. Sci Rep 9:1733. https:\/\/doi.org\/10.1038\/s41598-018-38271-2","journal-title":"Sci Rep"},{"issue":"7","key":"4467_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011820","volume":"5","author":"FJ Sepulveda","year":"2010","unstructured":"Sepulveda FJ, Parodi J, Peoples RW et al (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS ONE 5(7):e11820. https:\/\/doi.org\/10.1371\/journal.pone.0011820","journal-title":"PLoS ONE"},{"issue":"6","key":"4467_CR42","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/jnc.13060","volume":"132","author":"CR Pacheco","year":"2015","unstructured":"Pacheco CR, Morales CN, Ram\u00edrez AE et al (2015) Extracellular \u03b1-synuclein alters synaptic transmission in brain neurons by perforating the neuronal plasma membrane. J Neurochem 132(6):731\u2013741. https:\/\/doi.org\/10.1111\/jnc.13060","journal-title":"J Neurochem"},{"key":"4467_CR43","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/dneu.22607","volume":"78","author":"TH Ipsen","year":"2018","unstructured":"Ipsen TH, Polli FS, Kohlmeier KA (2018) Calcium rises induced by AMPA and nicotine receptors in the ventral tegmental area show differences in mouse brain slices prenatally exposed to nicotine. Dev Neurobiol 78:828\u2013848. https:\/\/doi.org\/10.1002\/dneu.22607","journal-title":"Dev Neurobiol"},{"key":"4467_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jneumeth.2016.01.020","volume":"263","author":"M Veleanu","year":"2016","unstructured":"Veleanu M, Axen TE, Kristensen MP, Kohlmeier KA (2016) Comparison of bNOS and chat immunohistochemistry in the laterodorsal tegmentum (LDT) and the pedunculopontine tegmentum (PPT) of the mouse from brain slices prepared for electrophysiology. J Neurosci Methods 263:23\u201335. https:\/\/doi.org\/10.1016\/j.jneumeth.2016.01.020","journal-title":"J Neurosci Methods"},{"key":"4467_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jnc.13045","volume":"132","author":"A Surguchev","year":"2015","unstructured":"Surguchev A, Surguchov A (2015) Effect of \u03b1-synuclein on membrane permeability and synaptic transmission: a clue to neurodegeneration? J Neurochem 132:619\u2013621. https:\/\/doi.org\/10.1111\/jnc.13045","journal-title":"J Neurochem"},{"issue":"6","key":"4467_CR46","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","volume":"279","author":"IF Tsigelny","year":"2012","unstructured":"Tsigelny IF, Sharikov Y, Wrasidlo W et al (2012) Role of \u03b1-synuclein penetration into the membrane in the mechanisms of oligomer pore formation. FEBS J 279(6):1000\u20131013. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08489.x","journal-title":"FEBS J"},{"key":"4467_CR47","doi-asserted-by":"publisher","first-page":"e44617","DOI":"10.15252\/embr.201744617","volume":"19","author":"C Betzer","year":"2018","unstructured":"Betzer C, Lassen LB, Olsen A et al (2018) Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Rep 19:e44617. https:\/\/doi.org\/10.15252\/embr.201744617","journal-title":"EMBO Rep"},{"key":"4467_CR48","doi-asserted-by":"publisher","first-page":"29950","DOI":"10.1074\/JBC.M803992200","volume":"283","author":"F Pellistri","year":"2008","unstructured":"Pellistri F, Bucciantini M, Relini A et al (2008) Nonspecific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells. J Biol Chem 283:29950\u201329960. https:\/\/doi.org\/10.1074\/JBC.M803992200","journal-title":"J Biol Chem"},{"key":"4467_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/FNMOL.2019.00237\/BIBTEX","volume":"12","author":"E Leandrou","year":"2019","unstructured":"Leandrou E, Emmanouilidou E, Vekrellis K (2019) Voltage-gated calcium channels and \u03b1-synuclein: implications in Parkinson\u2019s disease. Front Mol Neurosci 12:237. https:\/\/doi.org\/10.3389\/FNMOL.2019.00237\/BIBTEX","journal-title":"Front Mol Neurosci"},{"key":"4467_CR50","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","volume":"32","author":"MJ Diogenes","year":"2012","unstructured":"Diogenes MJ, Dias RB, Rombo DM et al (2012) Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair ltp Via NMDA-receptor activation. J Neurosci 32:11750\u201311762. https:\/\/doi.org\/10.1523\/JNEUROSCI.0234-12.2012","journal-title":"J Neurosci"},{"issue":"1","key":"4467_CR51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.brainres.2006.09.079","volume":"1124","author":"S Jae Kim","year":"2006","unstructured":"Jae Kim S, Yul Kim S, Na YS et al (2006) \u03b1-Synuclein enhances dopamine D2 receptor signaling. Brain Res 1124(1):5\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2006.09.079","journal-title":"Brain Res"},{"issue":"1","key":"4467_CR52","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1124\/jpet.106.111690","volume":"320","author":"TK Aman","year":"2007","unstructured":"Aman TK, Shen RY, Haj-Dahmane S (2007) D2-like dopamine receptors depolarize dorsal raphe serotonin neurons through the activation of nonselective cationic conductance. J Pharmacol Exp Ther 320(1):376\u2013385. https:\/\/doi.org\/10.1124\/jpet.106.111690","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4467_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1460-9568.2010.07266.x","volume":"32","author":"LR Feng","year":"2010","unstructured":"Feng LR, Federoff HJ, Vicini S, Maguire-Zeiss KA (2010) \u03b1-Synuclein mediates alterations in membrane conductance: A potential role for \u03b1-synuclein oligomers in cell vulnerability. Eur J Neurosci 32(1):10\u201317. https:\/\/doi.org\/10.1111\/j.1460-9568.2010.07266.x","journal-title":"Eur J Neurosci"},{"key":"4467_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042545","volume":"7","author":"F Schmidt","year":"2012","unstructured":"Schmidt F, Levin J, Kamp F et al (2012) Single-channel electrophysiology reveals a distinct and uniform pore complex formed by \u03b1-synuclein oligomers in lipid membranes. PLoS ONE 7:e42545. https:\/\/doi.org\/10.1371\/journal.pone.0042545","journal-title":"PLoS ONE"},{"issue":"19","key":"4467_CR55","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.15252\/embj.201591397","volume":"34","author":"AN Shrivastava","year":"2015","unstructured":"Shrivastava AN, Redeker V, Fritz N et al (2015) \u03b1-synuclein assemblies sequester neuronal \u03b13-Na +\/K + - ATP ase and impair Na + gradient. EMBO J 34(19):2408\u20132423. https:\/\/doi.org\/10.15252\/embj.201591397","journal-title":"EMBO J"},{"key":"4467_CR56","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/19336950.2015.1063285","volume":"9","author":"G Ronzitti","year":"2015","unstructured":"Ronzitti G, Bucci G, Stephens G, Chieregatti E (2015) Raft-partitioning of calcium channels regulates their function. Channels 9:169\u2013170. https:\/\/doi.org\/10.1080\/19336950.2015.1063285","journal-title":"Channels"},{"issue":"1","key":"4467_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1471-4159.2006.03731.x","volume":"97","author":"KJ Ahn","year":"2006","unstructured":"Ahn KJ, Paik SR, Chung KC, Kim J (2006) Amino acid sequence motifs and mechanistic features of the membrane translocation of \u03b1-synuclein. J Neurochem 97(1):265\u2013279. https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03731.x","journal-title":"J Neurochem"},{"issue":"8","key":"4467_CR58","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00702-011-0592-y","volume":"118","author":"J Yin","year":"2011","unstructured":"Yin J, Han J, Zhang C et al (2011) C-terminal part of \u03b1-synuclein mediates its activity in promoting proliferation of dopaminergic cells. J Neural Transm 118(8):1155\u20131164. https:\/\/doi.org\/10.1007\/s00702-011-0592-y","journal-title":"J Neural Transm"},{"key":"4467_CR59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193763","author":"GC Hassink","year":"2018","unstructured":"Hassink GC, Raiss CC, Segers-Nolten IMJ et al (2018) Exogenous \u03b1-synuclein hinders synaptic communication in cultured cortical primary rat neurons. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0193763","journal-title":"PLoS ONE"},{"key":"4467_CR60","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1523\/JNEUROSCI.22-07-02862.2002","volume":"22","author":"S Burlet","year":"2002","unstructured":"Burlet S, Tyler CJ, Leonard CS (2002) Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin\/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22:2862\u20132872. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-07-02862.2002","journal-title":"J Neurosci"},{"issue":"1","key":"4467_CR61","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1152\/jn.00076.2004","volume":"92","author":"KA Kohlmeier","year":"2004","unstructured":"Kohlmeier KA, Inoue T, Leonard CS (2004) Hypocretin\/orexin peptide signaling in the ascending arousal system: elevation of intracellular calcium in the mouse dorsal raphe and Laterodorsal Tegmentum. J Neurophysiol 92(1):221\u2013235. https:\/\/doi.org\/10.1152\/jn.00076.2004","journal-title":"J Neurophysiol"},{"key":"4467_CR62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.EURONEURO.2020.07.008","volume":"38","author":"CR Romero-Leguizam\u00f3n","year":"2020","unstructured":"Romero-Leguizam\u00f3n CR, Kohlmeier KA (2020) Stress-related endogenous neuropeptides induce neuronal excitation in the Laterodorsal Tegmentum. Eur Neuropsychopharmacol 38:86\u201397. https:\/\/doi.org\/10.1016\/J.EURONEURO.2020.07.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"4467_CR63","doi-asserted-by":"publisher","DOI":"10.1101\/2022.02.21.481193","author":"A Kowalski","year":"2022","unstructured":"Kowalski A, Betzer C, Larsen ST et al (2022) Monomeric \u03b1-synuclein activates the plasma membrane calcium pump. bioRxiv. https:\/\/doi.org\/10.1101\/2022.02.21.481193","journal-title":"bioRxiv"},{"key":"4467_CR64","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/neu.480230915","volume":"23","author":"DW Choi","year":"1992","unstructured":"Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261\u20131276. https:\/\/doi.org\/10.1002\/neu.480230915","journal-title":"J Neurobiol"},{"key":"4467_CR65","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","volume":"460","author":"A Lau","year":"2010","unstructured":"Lau A, Tymianski M (2010) Glutamate receptors, neurotoxicity and neurodegeneration. Pfl\u00fcgers Arch Eur J Physiol 460:525\u2013542. https:\/\/doi.org\/10.1007\/s00424-010-0809-1","journal-title":"Pfl\u00fcgers Arch Eur J Physiol"},{"key":"4467_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1469-7793.1999.0451m.x","volume":"519","author":"O Vergun","year":"1999","unstructured":"Vergun O, Keelan J, Khodorov BI, Duchen MR (1999) Glutamate-induced mitochondrial depolarisation and perturbation of calcium homeostasis in cultured rat hippocampal neurones. J Physiol 519:451\u2013466. https:\/\/doi.org\/10.1111\/j.1469-7793.1999.0451m.x","journal-title":"J Physiol"},{"key":"4467_CR67","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1469-7793.2001.0147j.x","volume":"531","author":"O Vergun","year":"2001","unstructured":"Vergun O, Sobolevsky AI, Yelshansky MV et al (2001) Exploration of the role of reactive oxygen species in glutamate neurotoxicity in rat hippocampal neurones in culture. J Physiol 531:147\u2013163. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.0147j.x","journal-title":"J Physiol"},{"key":"4467_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/1577","author":"AK Stout","year":"1998","unstructured":"Stout AK, Raphael HM, Kanterewicz BI et al (1998) Glutamate-induced neuron death requires mitochondrial calcium uptake. Nat Neurosci. https:\/\/doi.org\/10.1038\/1577","journal-title":"Nat Neurosci"},{"issue":"5","key":"4467_CR69","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0306-4522(98)00441-2","volume":"1","author":"AK Stout","year":"1999","unstructured":"Stout AK, Reynolds IJ (1999) High-affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations. Neuroscience 1(5):366\u2013373. https:\/\/doi.org\/10.1016\/S0306-4522(98)00441-2","journal-title":"Neuroscience"},{"issue":"3","key":"4467_CR70","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbagen.2009.08.002","volume":"800","author":"AY Abramov","year":"2010","unstructured":"Abramov AY, Duchen MR (2010) Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons. Biochim Biophys Acta Gen Subj 800(3):297\u2013304. https:\/\/doi.org\/10.1016\/j.bbagen.2009.08.002","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"3","key":"4467_CR71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/cdd.2012.142","volume":"20","author":"S B\u00fcttner","year":"2013","unstructured":"B\u00fcttner S, Faes L, Reichelt WN et al (2013) The Ca 2+\/Mn 2+ ion-pump PMR1 links elevation of cytosolic Ca 2+ levels to -synuclein toxicity in Parkinson\u2019s disease models. Cell Death Differ 20(3):465\u2013477. https:\/\/doi.org\/10.1038\/cdd.2012.142","journal-title":"Cell Death Differ"},{"key":"4467_CR72","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP et al (2011) Exogenous \u03b1-synuclein fibrils induce lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 72:57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"issue":"1","key":"4467_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.07.086","volume":"123","author":"C Humpel","year":"2015","unstructured":"Humpel C (2015) Organotypic brain slice cultures: a review. Neuroscience 123(1):e59. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.07.086","journal-title":"Neuroscience"},{"key":"4467_CR74","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1113\/JP271968","volume":"594","author":"TJ Kaufmann","year":"2016","unstructured":"Kaufmann TJ, Harrison PM, Richardson MJE et al (2016) Intracellular soluble \u03b1-synuclein oligomers reduce pyramidal cell excitability. J Physiol 594:2751\u20132772. https:\/\/doi.org\/10.1113\/JP271968","journal-title":"J Physiol"},{"key":"4467_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U et al (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134. https:\/\/doi.org\/10.1007\/s00441-004-0956-9","journal-title":"Cell Tissue Res"},{"key":"4467_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","volume":"213","author":"B Mollenhauer","year":"2008","unstructured":"Mollenhauer B, Cullen V, Kahn I et al (2008) Direct quantification of CSF \u03b1-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. Exp Neurol 213:315\u2013325. https:\/\/doi.org\/10.1016\/j.expneurol.2008.06.004","journal-title":"Exp Neurol"},{"key":"4467_CR77","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/scitranslmed.3002566","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, Shi M, Chung KA et al (2012) Phosphorylated -Synuclein in Parkinson\u2019s Disease. Sci Transl Med 4:121ra20. https:\/\/doi.org\/10.1126\/scitranslmed.3002566","journal-title":"Sci Transl Med"},{"issue":"6","key":"4467_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-019-0103-7","volume":"61","author":"S Fanning","year":"2020","unstructured":"Fanning S, Selkoe D, Dettmer U (2020) Parkinson\u2019s disease: proteinopathy or lipidopathy? npj Parkinsons Dis 61(6):1\u20139. https:\/\/doi.org\/10.1038\/s41531-019-0103-7","journal-title":"npj Parkinsons Dis"},{"key":"4467_CR79","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.3233\/JPD-202141","volume":"10","author":"CM Von Euler","year":"2020","unstructured":"Von Euler CM, S\u00f6derberg L, F\u00e4lting J et al (2020) Alpha-synuclein protofibrils in cerebrospinal fluid: a potential biomarker for Parkinson\u2019s disease. J Parkinsons Dis 10:1429\u20131442. https:\/\/doi.org\/10.3233\/JPD-202141","journal-title":"J Parkinsons Dis"},{"key":"4467_CR80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5665\/sleep.5300","volume":"39","author":"CH Schenck","year":"2016","unstructured":"Schenck CH (2016) Expanded insights into idiopathic REM sleep behavior disorder. Sleep 39:7\u20139. https:\/\/doi.org\/10.5665\/sleep.5300","journal-title":"Sleep"},{"key":"4467_CR81","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42642","author":"C Karachi","year":"2010","unstructured":"Karachi C, Grabli D, Bernard FA et al (2010) Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI42642","journal-title":"J Clin Invest"},{"key":"4467_CR82","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","volume":"74","author":"S Gilman","year":"2010","unstructured":"Gilman S, Koeppe RA, Nan B et al (2010) Cerebral cortical and subcortical cholinergic deficits in Parkinsonian syndromes. Neurology 74:1416\u20131423. https:\/\/doi.org\/10.1212\/WNL.0b013e3181dc1a55","journal-title":"Neurology"},{"issue":"9","key":"4467_CR83","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","volume":"13","author":"MLTM M\u00fcller","year":"2013","unstructured":"M\u00fcller MLTM, Bohnen NI (2013) Cholinergic dysfunction in parkinson\u2019s disease. Curr Neurol Neurosci Rep 13(9):377. https:\/\/doi.org\/10.1007\/s11910-013-0377-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4467_CR84","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P et al (2012) Identifying prodromal Parkinson\u2019s disease: Pre-Motor disorders in Parkinson\u2019s disease. Mov Disord 27:617\u2013626. https:\/\/doi.org\/10.1002\/mds.24996","journal-title":"Mov Disord"},{"key":"4467_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0196056","volume":"13","author":"L Berkhoudt Lassen","year":"2018","unstructured":"Berkhoudt Lassen L, Gregersen E, Kathrine Isager A et al (2018) ELISA method to detect \u03b1-synuclein oligomers in cell and animal models. PLoS ONE 13:e0196056. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0196056","journal-title":"PLoS ONE"},{"key":"4467_CR86","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1074\/JBC.M806559200","volume":"284","author":"S Emadi","year":"2009","unstructured":"Emadi S, Kasturirangan S, Wang MS et al (2009) Detecting morphologically distinct oligomeric forms of alpha-synuclein. J Biol Chem 284:11048\u201311058. https:\/\/doi.org\/10.1074\/JBC.M806559200","journal-title":"J Biol Chem"},{"key":"4467_CR87","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/J.SNB.2017.08.051","volume":"255","author":"A Khatri","year":"2018","unstructured":"Khatri A, Punjabi N, Ghosh D et al (2018) Detection and differentiation of \u03b1-Synuclein monomer and fibril by chitosan film coated nanogold array on optical sensor platform. Sensors Actuators B Chem 255:692\u2013700. https:\/\/doi.org\/10.1016\/J.SNB.2017.08.051","journal-title":"Sensors Actuators B Chem"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04467-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04467-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T14:53:13Z","timestamp":1661179993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04467-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":87,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["4467"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04467-z","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"22 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that there are no conflicts of interest in regard to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"upon acceptance, data are available at a repository at the university of copenhagen and made available upon reasonable request to the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"data availability"}},{"value":"Animals were used under approval in accordance with European Communities Council Directive (86\/609\/EEC).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"ethics approval"}},{"value":"In the data set reporting amplitudes of effects with monomer and fibril, some of the same data were used in a previously published study (2021;11(4):1773\u20131790. ). However, the present report represents a distinctly different study as it examines a hypothesis, and presents conclusions which are different from those in the earlier publication. In addition, we present the results of many new experiments in this report.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement about data used in another study"}}],"article-number":"450"}}